Relief Therapeutics Holding AG

Zevra Therapeutics is to acquire struggling Acer Therapeutics Inc. to expands its rare disease activities and add a commercial product for urea cycle disorders (UCDs). In a deal worth up to $91m, i

The European Medicines Agency has begun assessing an application for the approval of the Pfizer Inc. / BioNTech SE COVID-19 vaccine, Comirnaty, in children aged five to 11 years. The vaccine, which

Germany is coming under pressure to drop its opposition to a proposed waiver of intellectual property protections on COVID-19 products after more than 140 former heads of state and government and Nobe

There is no urgent need to administer booster COVID-19 vaccines to fully vaccinated people in the general European population, because evidence to date shows that all vaccines authorized in the EU are